Patents by Inventor Chi-Ting Hsieh

Chi-Ting Hsieh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biodegradable marker pen
    Patent number: 12214617
    Abstract: A biodegradable marker pen including a barrel, a cap, and an ink reservoir. The barrel has a hollow cylindrical structure, the ink reservoir is placed in the barrel, and the cap is detachably coupled with the barrel hermetically. The barrel, the cap, and the ink reservoir comprise 2 to 10 mass percentage of a biodegradable masterbatch respectively.
    Type: Grant
    Filed: January 9, 2024
    Date of Patent: February 4, 2025
    Assignee: Sunny Pro Co., Ltd.
    Inventors: Chi-Ting Hsieh, Jung-Shan Huang, Shun-Chih Fang, Chao-Han Huang, Siu-Hei Choi
  • BIODEGRADABLE MARKER PEN
    Publication number: 20240227428
    Abstract: A biodegradable marker pen including a barrel, a cap, and an ink reservoir. The barrel has a hollow cylindrical structure, the ink reservoir is placed in the barrel, and the cap is detachably coupled with the barrel hermetically. The barrel, the cap, and the ink reservoir comprise 2 to 10 mass percentage of a biodegradable masterbatch respectively.
    Type: Application
    Filed: January 9, 2024
    Publication date: July 11, 2024
    Inventors: Chi-Ting Hsieh, Jung-Shan Huang, Shun-Chih Fang, Chao-Han Huang, Siu-Hei Choi
  • COMPOSITION FOR TREATING METABOLIC SYNDROME AND A PREPARATION METHOD THEREOF
    Publication number: 20160214918
    Abstract: A compound for treating a metabolic syndrome, comprising a structure of a 6Cs unit-3Cs unit-6Cs unit (C6-C3-C6) as shown in formula I, wherein: when R1 and R2 are both hydrogens, C3 has only single bonds; when R1 is an oxygen and R2 is one selected from a group consisting of an alkoxy, a benzyloxy and a halogen, C3 has only single bonds; when R1 is a deuterium and R2 is one selected from a group consisting of a hydrogen, an alkoxy, a benzyloxy and a halogen, C3 has one of a single bond and a double bond.
    Type: Application
    Filed: January 21, 2016
    Publication date: July 28, 2016
    Applicant: Kaohsiung Medical University
    Inventors: Fang-Rong Chang, Yang-Chang Wu, Tusty-Jiuan Hsieh, Chi-Ting Hsieh, Ferenc Fülöp, Sándor Balázs Ötvös
  • Composition for treating diabetes and metabolic diseases and a preparation method thereof
    Patent number: 9085520
    Abstract: Disclosed is a chalcone composition for treating diabetes and metabolic syndromes. In particular, the chalcone compound bound with 2-halogen in ring A significantly decreases the blood glucose level in the in vitro anti-diabetic effect experiment. In the in vivo animal model, the leading chalcone compound can prevent the progression of diabetes and control the blood glucose level, and there is no significant difference in the gains in body weight. Throughout the seven-week administration, there are no hepatic or renal toxicity observed.
    Type: Grant
    Filed: August 8, 2012
    Date of Patent: July 21, 2015
    Assignee: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Yang-Chang Wu, Fang-Rong Chang, Tusty-Jiuan Hsieh, Ying-Chi Du, Yi-Hong Tsai, Chi-Ting Hsieh
  • COMPOSITION FOR TREATING DIABETES AND METABOLIC DISEASES AND A PREPARATION METHOD THEREOF
    Publication number: 20140350304
    Abstract: Disclosed is a chalcone composition for treating diabetes and metabolic syndromes. In particular, the chalcone compound bound with 2-halogen in ring A significantly decreases the blood glucose level in the in vitro anti-diabetic effect experiment. In the in vivo animal model, the leading chalcone compound can prevent the progression of diabetes and control the blood glucose level, and there is no significant difference in the gains in body weight. Throughout the seven-week administration, there are no hepatic or renal toxicity observed.
    Type: Application
    Filed: August 8, 2012
    Publication date: November 27, 2014
    Applicant: KAOHSIUNG MEDICAL UNIVERSITY
    Inventors: Yang-Chang Wu, Fang-Rong Chang, Tusty-Jiuan Hsieh, Ying-chi Du, Yi-Hong Tsai, Chi-Ting Hsieh
  • Extracts of hulls and use thereof in the treatment of cancer
    Patent number: 8168238
    Abstract: The invention discloses an ethyl acetate layer of methanol extract of Aquilaria hulls for killing cancer cells and treating/preventing cancers and its uses. The extracts of Aquilaria hulls has an significant amount of cucurbitacins and these cucurbitacins are effective in killing cancer cells and treating/preventing cancers.
    Type: Grant
    Filed: December 29, 2009
    Date of Patent: May 1, 2012
    Assignee: Taipei Medical University
    Inventors: Ching-Chiung Wang, Lih-Geeng Chen, Ting-Lin Chang, Chi-Ting Hsieh
  • EXTRACTS OF AQUILARIA HULLS AND USE THEREOF IN THE TREATMENT OF CANCER
    Publication number: 20110160152
    Abstract: The invention discloses an ethyl acetate layer of methanol extract of Aquilaria hulls for killing cancer cells and treating/preventing cancers and its uses. The extracts of Aquilaria hulls has an significant amount of cucurbitacins and these cucurbitacins are effective in killing cancer cells and treating/preventing cancers.
    Type: Application
    Filed: December 29, 2009
    Publication date: June 30, 2011
    Applicant: TAIPEI MEDICAL UNIVERSITY
    Inventors: Ching-Chiung Wang, Lih-Geeng Chen, Ting-Lin Chang, Chi-Ting Hsieh